𝛼SK or SearchD. Western Therapeutics Institute (4576 JP) - March 26, 2026
SUMMARY
- On March 25, 2026, D. Western Therapeutics Institute, Inc. (DWTI, the Company) announced a capital and business alliance with Senju Pharmaceutical Co., Ltd., a company with strengths in the ophthalmology field.
- As part of this alliance, the Company will conduct a third-party allotment of new shares to Senju Pharmaceutical (scheduled for April 10), raising JPY 199.9 mn.
- The funds raised will be used to advance the development of H-1337, a glaucoma treatment currently under development by the Company, in Japan (specifically, as preparatory funds for additional non-clinical trials in Japan).
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- D. Western Therapeutics Institute (4576 JP) - March 26, 202631 Mar 2026
x